FIELD: medicine.
SUBSTANCE: invention refers to medicine and is intended for complex treatment of ulcerative colitis. Rectal suppositories containing vitamin D3 aqueous solution – 1,500 IU are used; polyethylene glycol 1500 – 0.3 g; polyethylene glycol 6000 – 0.5 g; emulsifier T-2 – 0.1 g; Cremophore RH-40 – 1.15 g; lutrol F-127 – 0.55 g.
EFFECT: agent widens the range of therapeutic agents.
1 cl, 5 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIOXIDANT PREPARATION WITH 5-AMINOSALICYLIC ACID, QUERCETIN AND PROPOLIS EXTRACT | 2012 |
|
RU2498810C1 |
RECTAL SUPPOSITORIES, HAVING ANTI-INFLAMMATORY, ANTIOXIDANT, IMMUNOSTIMULATING ACTION, CONTAINING RHIZOMES WITH COMMON TURMERIC ROOTS | 2020 |
|
RU2743427C1 |
DOSAGE FORM FOR TREATING AND PREVENTING ULCERATIVE COLITIS, CONTAINING PEGYLATED LIPOSOMAL FORM OF ERYTHROPOIETIN IN FORM OF SUPPOSITORIES, HAVING ANTI-INFLAMMATORY AND IMMUNOMODULATORY EFFECT | 2020 |
|
RU2740060C1 |
CALCIUM GLUCONATE NANOSUBSTANCE SUPPOSITORIES FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY (VERSIONS) | 2012 |
|
RU2511649C1 |
MELATONIN AGENT FOR TREATING INFLAMMATORY BOWEL DISEASES IN THE FORM OF RECTAL SUPPOSITORIES | 2023 |
|
RU2819721C1 |
RECTAL SUPPOSITORIES WITH NICOTINIC ACID AND PROPOLIS EXTRACT | 2013 |
|
RU2537242C1 |
RECTAL SUPPOSITORIES WITH ERYTHROPOIETIN, HAVING REPARATIVE AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2705723C1 |
AGENT WITH ALBUMIN AND PROPOLIS EXTRACT, EXHIBITING REPARATIVE ACTIVITY IN ANAEMIAS OF VARIOUS GENESIS | 2014 |
|
RU2571071C2 |
AGENT CONTAINING SUCCINIC ACID AND PROPOLIS EXTRACT AND POSSESSING DETOXIFICATION ACTIVITY | 2013 |
|
RU2538610C1 |
SUPPOSITORIES WITH BEE MOTH LARVAE EXTRACT AND BEE-GLUE EXTRACT FOR TREATING GYNECOPATHIES | 2010 |
|
RU2429867C1 |
Authors
Dates
2019-12-17—Published
2019-05-20—Filed